Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression

BACKGROUND: Clinical evidence that ketamine, a nonselective N-methyl-D-aspartate receptor (NMDAR) antagonist, has therapeutic effects within hours in people suffering from depression suggests that modulating glutamatergic neurotransmission is a fundamental step in alleviating the debilitating sympto...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Cornwell, Brian R., Salvadore, Giacomo, Furey, Maura, Marquardt, Craig A., Brutsche, Nancy E., Grillon, Christian, Zarate, Carlos A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3408548/
https://ncbi.nlm.nih.gov/pubmed/22521148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2012.03.029
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak